Riskpilot← Back to searchSign inGet full accessTPH MED AS
ASActiveOrg 989258362Langelandsvegen 42, 6010 ÅlesundAllmenn legetjeneste · NACE 86211Est. 20060 employees
Revenue 2022
NOK 1,1M
-18% vs 2021
EBITDA margin
27.4%
-44% vs 2021
Equity ratio
95.3%
Financial strength
Net profit 2022
NOK -135K
-117% vs 2021
| Revenue | NOK 1,1M | -18% |
| EBITDA | NOK 289K | -44% |
| Net profit | NOK -135K | -117% |
| Total assets | NOK 4,4M | -4% |
| Equity | NOK 4,2M | -3% |
| Employees | 0 | — |
Legal name
TPH MED AS
Org number
989258362
Legal form
Aksjeselskap
NACE code
86211 · Allmenn legetjeneste
Founded
18. februar 2006
Share capital
NOK 10 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Legevirksomhet.
Address
Langelandsvegen 42, 6010 Ålesund
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 578 | 1 025 | 1 031 | 1 241 | 1 519 | 1 334 | 1 364 | 1 445 | 1 391 | 1 375 | 1 390 | 1 311 | 1 490 | 1 283 | 1 055 |
| Staff expenses | −685 | −687 | −732 | −766 | −694 | −693 | −680 | −668 | −624 | −623 | −622 | −603 | −622 | −624 | −618 |
| EBITDA | 561 | 179 | 148 | 298 | 696 | 460 | 504 | 603 | 613 | 562 | 644 | 564 | 727 | 512 | 289 |
| Depreciation & amort. | −183 | −155 | −107 | −72 | −72 | −72 | −72 | −51 | −45 | −45 | −45 | −45 | −0 | −0 | −1 |
| EBIT | 378 | 24 | 41 | 227 | 624 | 388 | 433 | 552 | 568 | 517 | 599 | 519 | 727 | 512 | 289 |
| Net financials | 47 | 10 | 7 | 8 | 15 | −4 | 9 | 1 | 1 | 1 | 2 | 2 | 1 | 406 | −366 |
| Profit before tax | 425 | 34 | 48 | 235 | 639 | 384 | 441 | 553 | 569 | 518 | 600 | 521 | 728 | 918 | −77 |
| Tax | 120 | 9 | 13 | 66 | 179 | 107 | 119 | 148 | 142 | 124 | 139 | 115 | 160 | 108 | 58 |
| Net profit | 306 | 24 | 35 | 169 | 460 | 277 | 322 | 405 | 427 | 394 | 461 | 405 | 568 | 811 | −135 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 680 | 2 217 | 2 199 | 2 390 | 2 788 | 2 906 | 3 114 | 2 697 | 2 780 | 3 048 | 3 509 | 3 884 | 3 822 | 4 608 | 4 419 |
| Equity | 867 | 891 | 925 | 1 094 | 1 499 | 1 776 | 2 098 | 1 528 | 1 780 | 2 099 | 2 560 | 2 965 | 3 533 | 4 344 | 4 209 |
| Long-term debt | 0 | 0 | 0 | 0 | 250 | 162 | 77 | 25 | 17 | 9 | 1 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 295 | 895 | 895 | 978 | 1 040 | 968 | 939 | 1 144 | 983 | 941 | 948 | 919 | 289 | 264 | 210 |
| Total debt | 1 813 | 1 326 | 1 273 | 1 296 | 1 289 | 1 130 | 1 016 | 1 169 | 1 000 | 950 | 949 | 919 | 289 | 264 | 210 |
EBITDA margin
27.4%
This company
15.8%
Market median
+73% vs market
20082022
Equity ratio
95.3%
This company
38.2%
Market median
+149% vs market
20082022
Return on equity
-3.2%
This company
18.4%
Market median
-117% vs market
20082022
Net profit margin
-12.8%
This company
8.1%
Market median
-258% vs market
20082022
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
20082022
Debt / equity
0.05×
This company
0.62×
Market median
+92% vs market
20082022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TP Chief Executive Officer | Chief Executive Officer | 2006 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Chairman | 2023 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TPH MED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Terje Peder Håskjold | Chief Executive Officer | 0 companies |
| Johnny Stette | Board of Directors | 0 companies |
| Ellen Marie Håskjold | Chairman | 0 companies |